Symbols / LUCD Stock $1.06 -0.93% Lucid Diagnostics Inc.

Healthcare • Medical Devices • United States • NCM
LUCD (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Dr. Lishan Aklog M.D.
Exch · Country NCM · United States
Market Cap 199.66M
Enterprise Value 224.98M
Income -70.57M
Sales 4.71M
FCF (ttm) -26.26M
Book/sh -0.33
Cash/sh 0.21
Employees 82
Insider 10d —
IPO Oct 14, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -5.89
PEG —
P/S 42.43
P/B -3.20
P/C —
EV/EBITDA -4.61
EV/Sales 47.81
Quick Ratio 1.27
Current Ratio 1.31
Debt/Eq 236.10
LT Debt/Eq —
EPS (ttm) -0.69
EPS next Y -0.18
EPS Growth —
Revenue Growth 25.60%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-12
Earnings (prior) 2026-03-26
ROA -87.20%
ROE -7.11%
ROIC —
Gross Margin -41.73%
Oper. Margin -9.32%
Profit Margin 0.00%
Shs Outstand 188.36M
Shs Float 125.70M
Insider Own 25.92%
Instit Own 17.22%
Short Float 4.66%
Short Ratio 9.68
Short Interest 6.23M
52W High 1.70
vs 52W High -37.65%
52W Low 0.95
vs 52W Low 11.58%
Beta 1.25
Impl. Vol. —
Rel Volume 1.06
Avg Volume 782.17K
Volume 826.26K
Target (mean) $4.10
Tgt Median $3.00
Tgt Low $2.50
Tgt High $9.00
# Analysts 5
Recom Strong_buy
Prev Close $1.07
Price $1.06
Change -0.93%
About

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company's flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$4.10
Mean price target
2. Current target
$1.06
Latest analyst target
3. DCF / Fair value
$-2.51
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.06
Low
$2.50
High
$9.00
Mean
$4.10

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-09 main Ascendiant Capital Buy → Buy $9
2026-03-30 reit BTIG Buy → Buy $3
2026-03-26 reit Needham Buy → Buy $3
2025-12-10 main Ascendiant Capital Buy → Buy $8
2025-11-13 reit Needham Buy → Buy $3
2025-10-06 main Ascendiant Capital Buy → Buy $8
2025-09-10 reit BTIG Buy → Buy $3
2025-09-05 main BTIG Buy → Buy $3
2025-08-13 reit Needham Buy → Buy $3
2025-07-16 reit Needham Buy → Buy $3
2025-06-06 main Ascendiant Capital Buy → Buy $8
2025-05-15 reit Cantor Fitzgerald Overweight → Overweight $2
2025-05-14 reit Needham Buy → Buy $3
2025-04-21 main Ascendiant Capital Buy → Buy $8
2025-04-11 reit Needham Buy → Buy $3
2025-03-26 reit Cantor Fitzgerald Overweight → Overweight $2
2025-03-24 main Needham Buy → Buy $3
2024-12-09 main Ascendiant Capital Buy → Buy $7
2024-11-15 main Cantor Fitzgerald Overweight → Overweight $2
2024-11-14 main Canaccord Genuity Buy → Buy $3
News
RSS: Latest LUCD news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-20 SOKOLOV JACQUE J Director — 123,000 $0.00 $0
2026-02-20 MCGRATH DENNIS M Chief Financial Officer — 470,000 $0.00 $0
2026-02-20 LAPIDUS STANLEY N Director — 123,000 $0.00 $0
2026-02-20 PALUMBO JOHN R Director — 123,000 $0.00 $0
2026-02-20 AKLOG LISHAN Chief Executive Officer — 2,170,000 $0.00 $0
2026-02-20 COX JAMES L Director — 123,000 $0.00 $0
2026-02-20 MATHEIS DENNIS Director — 123,000 $0.00 $0
2026-02-20 WHITE DEBRA JAYNE Director — 123,000 $0.00 $0
2026-02-20 O'NEIL SHAUN President — 620,000 $0.00 $0
2026-02-20 GORDON MICHAEL ADAM General Counsel — 300,000 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
4.71
+8.28%
4.35
+79.00%
2.43
+544.03%
0.38
Operating Revenue
4.71
+8.28%
4.35
+79.00%
2.43
+544.03%
0.38
Cost Of Revenue
6.67
-6.04%
7.10
+18.73%
5.98
+65.44%
3.61
Reconciled Cost Of Revenue
6.22
-6.06%
6.62
+20.34%
5.50
+65.34%
3.33
Gross Profit
-1.96
+28.66%
-2.75
+22.47%
-3.55
-9.70%
-3.24
Operating Expense
47.68
+10.11%
43.30
-3.63%
44.93
-15.25%
53.01
Research And Development
5.68
-5.24%
5.99
-17.37%
7.25
-35.58%
11.26
Selling General And Administration
41.58
+13.54%
36.62
+2.70%
35.66
-11.10%
40.11
Selling And Marketing Expense
17.71
+7.57%
16.46
+0.36%
16.40
+1.67%
16.13
General And Administrative Expense
23.87
+18.41%
20.16
+4.68%
19.25
-19.69%
23.97
Other Gand A
23.87
+18.41%
20.16
+4.68%
19.25
-19.69%
23.97
Total Expenses
54.35
+7.83%
50.40
-1.01%
50.91
-10.10%
56.63
Operating Income
-49.64
-7.79%
-46.05
+5.01%
-48.48
+13.81%
-56.25
Total Operating Income As Reported
-49.64
-7.79%
-46.05
+5.01%
-48.48
+13.81%
-56.25
EBITDA
-57.12
-28.83%
-44.34
+10.88%
-49.75
+8.25%
-54.23
Normalized EBITDA
-57.12
-45.82%
-39.17
+21.23%
-49.73
+8.30%
-54.23
Reconciled Depreciation
0.87
-25.28%
1.17
-53.30%
2.50
+29.08%
1.94
EBIT
-57.99
-27.44%
-45.50
+12.91%
-52.25
+6.97%
-56.16
Total Unusual Items
0.00
+100.00%
-5.17
-19773.08%
-0.03
0.00
Total Unusual Items Excluding Goodwill
0.00
+100.00%
-5.17
-19773.08%
-0.03
0.00
Special Income Charges
0.00
+100.00%
-5.17
-19773.08%
-0.03
0.00
Other Special Charges
—
5.17
+19773.08%
0.03
—
Net Income
-58.01
-27.41%
-45.53
+13.55%
-52.67
+6.24%
-56.17
Pretax Income
-58.01
-27.41%
-45.53
+13.55%
-52.67
+6.24%
-56.17
Net Non Operating Interest Income Expense
0.36
+22.97%
0.30
+3600.00%
0.01
-90.00%
0.08
Interest Expense Non Operating
0.02
-15.38%
0.03
-93.75%
0.42
+5100.00%
0.01
Net Interest Income
0.36
+22.97%
0.30
+3600.00%
0.01
-90.00%
0.08
Interest Expense
0.02
-15.38%
0.03
-93.75%
0.42
+5100.00%
0.01
Interest Income Non Operating
0.39
+19.88%
0.32
-24.06%
0.42
+381.82%
0.09
Interest Income
0.39
+19.88%
0.32
-24.06%
0.42
+381.82%
0.09
Other Income Expense
-8.73
-3947.58%
0.23
+105.42%
-4.19
—
Other Non Operating Income Expenses
-8.73
-261.92%
5.39
+229.48%
-4.17
—
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-58.01
-27.41%
-45.53
+13.55%
-52.67
+6.24%
-56.17
Net Income From Continuing Operation Net Minority Interest
-58.01
-27.41%
-45.53
+13.55%
-52.67
+6.24%
-56.17
Net Income From Continuing And Discontinued Operation
-58.01
-27.41%
-45.53
+13.55%
-52.67
+6.24%
-56.17
Net Income Continuous Operations
-58.01
-27.41%
-45.53
+13.55%
-52.67
+6.24%
-56.17
Normalized Income
-58.01
-43.72%
-40.36
+23.32%
-52.64
+6.29%
-56.17
Net Income Common Stockholders
-70.57
-33.09%
-53.02
-0.68%
-52.67
+6.24%
-56.17
Diluted EPS
-0.43
+59.05%
-1.05
+16.67%
-1.26
+18.71%
-1.55
Basic EPS
-0.43
+59.05%
-1.05
+16.67%
-1.26
+18.71%
-1.55
Basic Average Shares
164.11
+224.98%
50.50
+20.94%
41.76
+15.44%
36.17
Diluted Average Shares
164.11
+224.98%
50.50
+20.94%
41.76
+15.44%
36.17
Diluted NI Availto Com Stockholders
-70.57
-33.09%
-53.02
-0.68%
-52.67
+6.24%
-56.17
Amortization
0.42
-38.81%
0.69
-65.96%
2.02
+22.56%
1.65
Amortization Of Intangibles Income Statement
0.42
-38.81%
0.69
-65.96%
2.02
+22.56%
1.65
Depreciation Amortization Depletion Income Statement
0.42
-38.81%
0.69
-65.96%
2.02
+22.56%
1.65
Depreciation And Amortization In Income Statement
0.42
-38.81%
0.69
-65.96%
2.02
+22.56%
1.65
Preferred Stock Dividends
12.56
+67.54%
7.50
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
40.45
+31.68%
30.71
+12.63%
27.27
-16.12%
32.51
Current Assets
37.47
+48.99%
25.15
+13.93%
22.07
-9.37%
24.36
Cash Cash Equivalents And Short Term Investments
34.70
+55.22%
22.36
+18.32%
18.90
-15.92%
22.47
Cash And Cash Equivalents
34.70
+55.22%
22.36
+18.32%
18.90
-15.92%
22.47
Cash Financial
34.70
+55.22%
22.36
+18.32%
18.90
-15.92%
22.47
Receivables
0.64
+58.77%
0.41
+800.00%
0.04
+164.71%
0.02
Accounts Receivable
0.64
+1328.89%
0.04
+0.00%
0.04
+164.71%
0.02
Inventory
0.35
+3.52%
0.34
+22.66%
0.28
+150.45%
0.11
Raw Materials
—
—
—
0.11
Prepaid Assets
1.77
-13.55%
2.04
-28.38%
2.85
+62.71%
1.75
Total Non Current Assets
2.98
-46.52%
5.57
+7.12%
5.20
-36.26%
8.15
Net PPE
2.62
-29.31%
3.70
+40.06%
2.64
-26.64%
3.60
Gross PPE
4.20
-13.39%
4.85
+42.19%
3.41
-12.37%
3.89
Accumulated Depreciation
-1.58
-37.93%
-1.15
-49.54%
-0.77
-165.40%
-0.29
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.47
+12.80%
0.41
+4.02%
0.40
+12.43%
0.35
Construction In Progress
—
—
—
0.00
Other Properties
3.70
-15.95%
4.40
+46.29%
3.01
-14.86%
3.53
Leases
0.03
+0.00%
0.03
+2900.00%
0.00
+0.00%
0.00
Goodwill And Other Intangible Assets
0.32
-57.20%
0.74
-48.31%
1.42
-58.66%
3.44
Other Intangible Assets
0.32
-57.20%
0.74
-48.31%
1.42
-58.66%
3.44
Non Current Prepaid Assets
—
—
—
—
Other Non Current Assets
0.05
-95.85%
1.13
+0.00%
1.13
+2.17%
1.11
Total Liabilities Net Minority Interest
29.51
+16.53%
25.32
-14.39%
29.58
+212.63%
9.46
Current Liabilities
28.58
+21.50%
23.52
-19.94%
29.38
+248.75%
8.43
Payables And Accrued Expenses
1.65
-23.92%
2.17
-82.74%
12.60
+91.36%
6.58
Payables
0.97
-21.84%
1.24
-88.16%
10.48
+74.29%
6.02
Accounts Payable
0.97
-21.84%
1.24
+8.29%
1.15
+8.52%
1.06
Current Accrued Expenses
0.68
-26.69%
0.93
-55.87%
2.11
+272.18%
0.57
Pensionand Other Post Retirement Benefit Plans Current
1.64
+10.75%
1.48
+25.55%
1.18
+34.02%
0.88
Current Debt And Capital Lease Obligation
24.89
+27.96%
19.45
+29.21%
15.06
+1465.07%
0.96
Current Debt
24.00
+29.03%
18.60
+33.33%
13.95
—
Other Current Borrowings
24.00
+29.03%
18.60
+33.33%
13.95
—
Current Capital Lease Obligation
0.89
+4.57%
0.85
-22.78%
1.11
+14.97%
0.96
Other Current Liabilities
0.40
-4.80%
0.42
-24.04%
0.55
—
Total Non Current Liabilities Net Minority Interest
0.93
-48.50%
1.80
+804.52%
0.20
-80.81%
1.04
Long Term Debt And Capital Lease Obligation
0.93
-48.50%
1.80
+804.52%
0.20
-80.81%
1.04
Long Term Capital Lease Obligation
0.93
-48.50%
1.80
+804.52%
0.20
-80.81%
1.04
Stockholders Equity
10.94
+102.86%
5.39
+333.28%
-2.31
-110.03%
23.05
Common Stock Equity
-43.34
+11.61%
-49.03
-134.18%
-20.94
-190.84%
23.05
Capital Stock
54.41
-0.14%
54.48
+191.86%
18.67
+45429.27%
0.04
Common Stock
0.13
+107.94%
0.06
+50.00%
0.04
+2.44%
0.04
Preferred Stock
54.27
-0.27%
54.42
+192.18%
18.62
0.00
Share Issued
131.10
+107.86%
63.07
+49.00%
42.33
+4.47%
40.52
Ordinary Shares Number
131.10
+107.86%
63.07
+49.00%
42.33
+4.47%
40.52
Additional Paid In Capital
230.87
+49.26%
154.68
+19.20%
129.76
+7.17%
121.08
Retained Earnings
-274.33
-34.63%
-203.77
-35.18%
-150.74
-53.70%
-98.08
Total Equity Gross Minority Interest
10.94
+102.86%
5.39
+333.28%
-2.31
-110.03%
23.05
Total Capitalization
10.94
+102.86%
5.39
+333.28%
-2.31
-110.03%
23.05
Working Capital
8.89
+447.17%
1.62
+122.22%
-7.31
-145.88%
15.93
Invested Capital
-19.34
+36.45%
-30.43
-335.56%
-6.99
-130.31%
23.05
Total Debt
25.82
+21.48%
21.25
+39.32%
15.26
+663.13%
2.00
Capital Lease Obligations
1.82
-31.42%
2.65
+103.37%
1.30
-34.72%
2.00
Net Tangible Assets
10.62
+128.16%
4.66
+224.63%
-3.73
-119.05%
19.60
Tangible Book Value
-43.65
+12.28%
-49.76
-122.56%
-22.36
-214.07%
19.60
Duefrom Related Parties Current
0.00
-100.00%
0.36
0.00
—
Dueto Related Parties Current
—
0.00
-100.00%
9.34
+88.29%
4.96
Preferred Stock Equity
54.27
-0.27%
54.42
+192.18%
18.62
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-46.48
-5.31%
-44.14
-34.50%
-32.82
-10.55%
-29.68
Cash Flow From Continuing Operating Activities
-46.48
-5.31%
-44.14
-34.50%
-32.82
-10.55%
-29.68
Net Income From Continuing Operations
-58.01
-27.41%
-45.53
+13.55%
-52.67
+6.24%
-56.17
Depreciation Amortization Depletion
0.87
-25.28%
1.17
-53.30%
2.50
+29.08%
1.94
Depreciation
0.45
-5.85%
0.48
+0.21%
0.48
+66.55%
0.29
Amortization Cash Flow
0.42
-38.81%
0.69
-65.96%
2.02
+22.56%
1.65
Depreciation And Amortization
0.87
-25.28%
1.17
-53.30%
2.50
+29.08%
1.94
Amortization Of Intangibles
0.42
-38.81%
0.69
-65.96%
2.02
+22.56%
1.65
Other Non Cash Items
1.31
+279.19%
0.35
-81.27%
1.85
+182.85%
0.65
Stock Based Compensation
4.49
-0.95%
4.53
-33.54%
6.82
-54.49%
14.99
Operating Gains Losses
—
5.17
+19773.08%
0.03
—
Unrealized Gain Loss On Investment Securities
7.66
+241.94%
-5.39
-281.01%
2.98
0.00
Change In Working Capital
-2.81
+36.67%
-4.43
-178.08%
5.67
-36.28%
8.91
Change In Receivables
-0.60
0.00
+100.00%
-0.03
-115.30%
0.18
Changes In Account Receivables
-0.60
0.00
+100.00%
-0.03
-115.30%
0.18
Change In Prepaid Assets
-1.84
-258.84%
1.16
+199.91%
-1.16
-199.74%
1.16
Change In Payables And Accrued Expense
-0.36
+93.49%
-5.59
-181.45%
6.86
-9.22%
7.56
Change In Accrued Expense
-0.11
+89.13%
-1.01
-142.27%
2.39
+618.92%
0.33
Change In Payable
-0.25
+94.45%
-4.58
-202.44%
4.47
-38.16%
7.23
Change In Account Payable
-0.27
-381.25%
0.10
+7.87%
0.09
+120.00%
-0.45
Investing Cash Flow
-0.20
+69.50%
-0.65
-192.31%
-0.22
+94.62%
-4.11
Cash Flow From Continuing Investing Activities
-0.20
+69.50%
-0.65
-192.31%
-0.22
+94.62%
-4.11
Net PPE Purchase And Sale
-0.20
+33.45%
-0.30
-33.94%
-0.22
+75.66%
-0.91
Purchase Of PPE
-0.20
+33.45%
-0.30
-33.94%
-0.22
+75.66%
-0.91
Capital Expenditure
-0.20
+69.50%
-0.65
-192.31%
-0.22
+75.66%
-0.91
Net Intangibles Purchase And Sale
0.00
+100.00%
-0.35
0.00
—
Purchase Of Intangibles
0.00
+100.00%
-0.35
0.00
—
Net Other Investing Changes
—
—
—
-3.20
Financing Cash Flow
59.03
+22.34%
48.25
+63.77%
29.46
+1028.30%
2.61
Cash Flow From Continuing Financing Activities
59.03
+22.34%
48.25
+63.77%
29.46
+1028.30%
2.61
Net Issuance Payments Of Debt
0.36
-98.00%
18.00
+79.99%
10.00
0.00
Issuance Of Debt
0.36
-98.33%
21.61
+116.15%
10.00
0.00
Repayment Of Debt
0.00
+100.00%
-3.62
0.00
—
Long Term Debt Issuance
—
—
10.00
0.00
Net Long Term Debt Issuance
—
—
10.00
0.00
Short Term Debt Issuance
0.36
-98.33%
21.61
+116.15%
10.00
—
Short Term Debt Payments
0.00
+100.00%
-3.62
0.00
—
Net Short Term Debt Issuance
0.36
-98.00%
18.00
+79.99%
10.00
—
Net Common Stock Issuance
58.38
0.00
-100.00%
0.28
-84.28%
1.81
Proceeds From Stock Option Exercised
0.29
-35.92%
0.45
-18.15%
0.55
-31.47%
0.80
Net Other Financing Charges
—
—
—
—
Changes In Cash
12.35
+256.64%
3.46
+196.76%
-3.58
+88.53%
-31.18
Beginning Cash Position
22.36
+18.32%
18.90
-15.92%
22.47
-58.11%
53.66
End Cash Position
34.70
+55.22%
22.36
+18.32%
18.90
-15.92%
22.47
Free Cash Flow
-46.68
-4.23%
-44.79
-35.56%
-33.04
-7.99%
-30.59
Common Stock Issuance
58.38
0.00
-100.00%
0.28
-84.28%
1.81
Issuance Of Capital Stock
58.38
+95.92%
29.80
+57.59%
18.91
+946.43%
1.81
Net Preferred Stock Issuance
0.00
-100.00%
29.80
+59.99%
18.62
0.00
Preferred Stock Issuance
0.00
-100.00%
29.80
+59.99%
18.62
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category